# Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor

> **NCT04866342** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 25 (actual)

## Conditions studied

- Premature
- Premature Infant
- Oxygen Therapy
- Hypoxia
- Hyperoxia
- Obstetric Labor, Premature

## Interventions

- **DEVICE:** Servo control (closed-loop automatic control of the inspiratory fraction of oxygen (FiO2)) - IntellO2 OAM

## Key facts

- **NCT ID:** NCT04866342
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-27
- **Primary completion:** 2023-08-28
- **Final completion:** 2023-08-28
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866342, "Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04866342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*